Kathleen M. Mulvaney

Statistics

Publications

Citations

654

H-Index

Active since

2013

Affiliations

University of North Carolina at Chapel Hill(Current)

UNC Lineberger Comprehensive Cancer Center

Broad Institute

Dana-Farber Cancer Institute

Harvard University

Kathleen M. Mulvaney is an author at University of North Carolina at Chapel Hill specializing in molecular biology, nrf2 pathway activation, and molecular oncology.

ORCID

Publications per year

2013–2021

Publications

Proteomic Analysis of Ubiquitin Ligase KEAP1 Reveals Associated Proteins That Inhibit NRF2 Ubiquitination

Bridgid E. Hast, Dennis Goldfarb, Kathleen M. Mulvaney et al. · Cancer Research · 2013 · 252 citations · Full text

Medicine, Molecular Biology, Oncology +17

Identification and Characterization of MCM3 as a Kelch-like ECH-associated Protein 1 (KEAP1) Substrate

Kathleen M. Mulvaney, Jacob P. Matson, Priscila F. Siesser et al. · Journal of Biological Chemistry · 2016 · 84 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +15

Molecular basis for substrate recruitment to the PRMT5 methylosome

Kathleen M. Mulvaney, Christa Blomquist, Nischal Acharya et al. · Molecular Cell · 2021 · 84 citations · Full text

Life Sciences, Genetics, Molecular Biology +6

Histone deacetylase inhibitors activate <scp>CIITA</scp> and MHC class <scp>II</scp> antigen expression in diffuse large B‐cell lymphoma

Kelly A. Cycon, Kathleen M. Mulvaney, Lisa M. Rimsza et al. · Immunology · 2013 · 78 citations · Full text

Medicine, Cancer Biology, Oncology +17

Discovery of a First-in-Class Inhibitor of the PRMT5–Substrate Adaptor Interaction

David C. McKinney, Brian J. McMillan, Matthew J. Ranaghan et al. · Journal of Medicinal Chemistry · 2021 · 52 citations · Full text

Pharmacy, Medicinal Chemistry, Molecular Biology +13

1–5 of 9